Td Asset Management Inc Intra Cellular Therapies, Inc. Transaction History

Td Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$46.37 - $73.65 $3.37 Million - $5.35 Million	72,648 New	72,648 $5.2 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $394,819 - $545,033	-16,916 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$17.61 - $31.86 $112,915 - $204,286	-6,412 Reduced 27.49%	16,916 $434,000
Q2 2020 Aug 13, 2020	SELL	$14.35 - $26.64 $177,940 - $330,336	-12,400 Reduced 34.71%	23,328 $599,000
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $70,511 - $189,711	5,728 Added 19.09%	35,728 $549,000
Q4 2019 Feb 11, 2020	BUY	$7.26 - $38.49 $217,800 - $1.15 Million	30,000 New	30,000 $1.03 Million
Q3 2019 Nov 07, 2019	SELL	$7.47 - $14.03 $111,303 - $209,047	-14,900 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$10.65 - $14.29 $7,455 - $10,003	700 Added 4.93%	14,900 $193,000
Q4 2018 Feb 01, 2019	SELL	$10.36 - $20.96 $71,484 - $144,624	-6,900 Reduced 32.7%	14,200 $162,000
Q3 2018 Nov 01, 2018	SELL	$17.77 - $22.9 $294,982 - $380,140	-16,600 Reduced 44.03%	21,100 $458,000
Q2 2018 Jul 31, 2018	SELL	$17.33 - $23.4 $197,561 - $266,760	-11,400 Reduced 23.22%	37,700 $666,000
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $744,356 - $1.25 Million	49,100 New	49,100 $1.03 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.